C OSBORNE to Paclitaxel
This is a "connection" page, showing publications C OSBORNE has written about Paclitaxel.
Connection Strength
0.084
-
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet. 2003 Aug 02; 362(9381):362-9.
Score: 0.049
-
Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study. Breast Cancer Res Treat. 1998 Sep; 51(2):169-81.
Score: 0.035